Research Paper

Using Biosen to Improve Growth-Coupled Evolutionary Pressure on Epimerases for D-Allulose Biosynthesis

If you formulate with D allulose, the enzyme that makes it is the bottleneck. D allulose comes from D fructose, and the conversion depends on ketose 3 epimerases, or KEases. These

If you formulate with D-allulose, the enzyme that makes it is the bottleneck. D-allulose comes from D-fructose, and the conversion depends on ketose 3-epimerases, or KEases. These enzymes work, but not always well enough. Some are slow. Some are heat-sensitive. At manufacturing scale, those limits raise costs and slow throughput.

The Enzyme Problem Behind Allulose Production

KEases catalyze a simple reaction: D-fructose becomes D-allulose. Simple, yes. Easy to industrialize, no. Most natural KEases are not built for high-temperature bioreactors. Their catalytic rates disappoint, and their thermal stability fades quickly. When an enzyme struggles, you need more of it. You also need longer reaction times. Both hurt the unit economics of allulose production.

Engineers usually respond with directed evolution. Mutate the enzyme, screen the variants, pick the best one. The trouble is screening. Classic assays require cell lysis, substrate incubation, and HPLC or colorimetric measurement. That is slow. It is labor-heavy. It limits how many mutants you can realistically evaluate.

What the Study Did

The researchers built a different approach. They used Biosen, a D-allulose-dependent biosensor, to create a growth-coupled in vivo screening platform. The logic is elegant. An active KEase turns fructose into allulose. The biosensor detects that allulose and triggers a growth signal in the host cell. Better enzymes produce more allulose. More allulose means faster growth. Faster growth means those cells win the culture.

This shifts the screening burden from manual assays to evolution itself. Instead of measuring each mutant, you let growth select it. The team applied this platform to an ADAE epimerase. Their goal was to push the enzyme beyond its natural limits.

Key Findings at a Glance

The best variant, M42, clearly outperformed the parental enzyme.

Metric M42 result Practical meaning
Catalytic activity 6.28x higher than parent Faster conversion per enzyme unit
Thermal half-life at 60°C 2.5x longer than parent Better stability during prolonged high-temperature use
D-allulose conversion from D-fructose 32.2% in 3 hours Strong yield for a single-step enzymatic reaction

The paper does not report the parent enzyme’s conversion number under the same conditions. That omission matters less than the trend. M42 is faster. M42 lasts longer. It also reaches a conversion level that would interest any production manager.

What It Means for Formulators and Buyers

This is more than a single improved enzyme. It is a better platform for finding improved enzymes. The growth-coupled biosensor lets you screen larger libraries in less time. You can explore more mutations and recover the rare ones that survive heat or boost activity. That shortens the development cycle for future KEase variants.

For ingredient buyers, the takeaway is practical. Enzyme expense is a major factor in allulose production. A variant like M42 could reduce enzyme loading per batch. Its extended half-life at 60°C also opens the door to higher operating temperatures. That can improve substrate handling and reaction kinetics in ways that matter at scale. None of this is proven in a commercial reactor yet. But the direction is right.

For formulators, better biocatalysts mean better supply stability. More efficient conversion lowers production cost. Lower production cost supports consistent pricing and availability. The paper does not include pilot-scale or food-grade validation, so do not spec M42 yet. Watch it. The method behind it, however, is already relevant to your supplier conversations.

Frequently Asked Questions

What does growth-coupled selection mean? The biosensor links enzyme activity to cell growth. When a variant produces D-allulose, the sensor activates a growth response. The best variant grows fastest. Over repeated culture rounds, superior mutants take over the population.

Is M42 ready for commercial allulose production? Not yet. The study demonstrates enzyme-level improvements, not industrial process performance. Reactor conditions, substrate quality, immobilization, and downstream purification still need testing. M42 is a strong lead, not a finished product.

What is ADAE? ADAE is a ketose 3-epimerase used for D-allulose synthesis. The abbreviation points to a specific enzyme in that family. The exact source organism does not change the core finding: the biosensor platform successfully engineered a more active, more stable version of it.

A Small Shift in Screening, A Large Shift in Output

This paper matters because it removes a bottleneck that slows every enzyme engineering project. The team did not just find one faster mutant. They built a selection system that can keep finding faster mutants. M42 already delivers a 6.28-fold activity gain and a 2.5-fold longer thermal half-life. The platform that produced those gains may deliver even better variants next time. That is the kind of progress ingredient buyers should watch closely.

Research Source

DOI: 10.1002/advs.202306478

View original paper

Need Allulose Application Guidance?

Our technical team can help evaluate allulose for sugar reduction, texture, browning, and label-planning projects.